The store will not work correctly when cookies are disabled.
(R)-N-(4-methoxyphenyl)-1-(1-phenylethyl)-1H-imidazole-5-carboxamide
ID: ALA4755808
PubChem CID: 162655991
Max Phase: Preclinical
Molecular Formula: C19H19N3O2
Molecular Weight: 321.38
Molecule Type: Unknown
Associated Items:
Names and Identifiers
Canonical SMILES: COc1ccc(NC(=O)c2cncn2[C@H](C)c2ccccc2)cc1
Standard InChI: InChI=1S/C19H19N3O2/c1-14(15-6-4-3-5-7-15)22-13-20-12-18(22)19(23)21-16-8-10-17(24-2)11-9-16/h3-14H,1-2H3,(H,21,23)/t14-/m1/s1
Standard InChI Key: NZVIHWQWEQLMCA-CQSZACIVSA-N
Molfile:
RDKit 2D
24 26 0 0 0 0 0 0 0 0999 V2000
11.6073 -8.2376 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
10.9882 -8.7805 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.1495 -9.5901 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
11.9333 -9.8579 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.5562 -9.3059 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
12.3877 -8.4983 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3349 -9.5658 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.5034 -10.3743 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
12.9425 -10.9800 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.3518 -11.6992 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
14.1570 -11.5334 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.2509 -10.7123 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9635 -10.3004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
15.6770 -10.7178 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
16.3938 -10.3060 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1040 -10.7253 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8202 -10.3141 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.8239 -9.4881 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
17.1054 -9.0750 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
16.3920 -9.4844 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
13.9536 -9.0213 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
14.9667 -9.4753 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
18.5401 -9.0796 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
19.2541 -9.4919 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
5 7 1 0
7 8 1 0
9 10 2 0
8 9 1 0
10 11 1 0
11 12 2 0
12 8 1 0
12 13 1 0
13 14 1 0
14 15 1 0
15 16 2 0
16 17 1 0
17 18 2 0
18 19 1 0
19 20 2 0
20 15 1 0
7 21 1 1
13 22 2 0
18 23 1 0
23 24 1 0
M END
Associated Targets(Human)
Molecule Features
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
Drug Indications
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanisms of Action
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Calculated Properties
Molecular Weight: 321.38 | Molecular Weight (Monoisotopic): 321.1477 | AlogP: 3.75 | #Rotatable Bonds: 5 |
Polar Surface Area: 56.15 | Molecular Species: NEUTRAL | HBA: 4 | HBD: 1 |
#RO5 Violations: ┄ | HBA (Lipinski): 5 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): ┄ |
CX Acidic pKa: ┄ | CX Basic pKa: 4.52 | CX LogP: 3.07 | CX LogD: 3.07 |
Aromatic Rings: 3 | Heavy Atoms: 24 | QED Weighted: 0.78 | Np Likeness Score: -1.19 |
References
1. Zhao S,Li X,Wang L,Peng W,Ye W,Li W,Wang YD,Chen WD. (2021) Design, synthesis and evaluation of 1-benzyl-1H-imidazole-5-carboxamide derivatives as potent TGR5 agonists., 32 [PMID:33440321] [10.1016/j.bmc.2020.115972] |